المؤلفون: Walma, MS, Rombouts, SJ, Brada, LJH, Rinkes, IHB, Bosscha, K, Bruijnen, RC, Busch, OR, Creemers, GJ, Daams, F, van Dam, RM, van Delden, OM, Festen, S, Ghorbani, P, de Groot, DJ, de Groot, JWB, Mohammad, NH, van Hillegersberg, R, de Hingh, IH, D'Hondt, M, Kerver, ED, van Leeuwen, MS, Liem, MS, van Lienden, KP, Los, M, de Meijer, VE, Meijerink, MR, Mekenkamp, LJ, Nio, CY, Abdennabi, IO, Pando, E, Patijn, GA, Polee, MB, Pruijt, JF, Roeyen, G, Ropela, JA, Stommel, MWJ, de Vos-Geelen, J, de Vries, JJ, van der Waal, EM, Wessels, FJ, Wilmink, JW, van Santvoort, HC, Besselink, MG, Molenaar, IQ

المصدر: Trials. 22(1):313

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146720775

المؤلفون: van Nassau SCMW; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Voogdt-Pruis HR; Department of Global Public Health and Bioethics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., de Jong VMW; Dutch patient federation for colorectal cancer (Stichting Darmkanker), Utrecht, the Netherlands., Otten HM; Department of Medical Oncology, Meander Medical Center Amersfoort, Amersfoort, the Netherlands., Valkenburg-van Iersel LB; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, GROW-School for Oncology and Developmental Biology, Maastricht, the Netherlands., Swarte BJ; Department of Medical Oncology, Maasstad Ziekenhuis, Rotterdam, the Netherlands., Buffart TE; Department of Medical Oncology, Amsterdam University Medical Centers, location VUMC, Amsterdam, the Netherlands., Pruijt HJ; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Mekenkamp LJ; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., May AM; Department of Epidemiology and Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

المصدر: PEC innovation [PEC Innov] 2024 Jun 07; Vol. 4, pp. 100300. Date of Electronic Publication: 2024 Jun 07 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 9918367980406676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-6282 (Electronic) Linking ISSN: 27726282 NLM ISO Abbreviation: PEC Innov Subsets: PubMed not MEDLINE

المؤلفون: van Nassau SC; Department of Medical Oncology, Division Cancer Center and Imaging, University Medical Center Utrecht, Utrecht, the Netherlands., Bond MJ; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Scheerman I; Department of Medical Oncology, Division Cancer Center and Imaging, University Medical Center Utrecht, Utrecht, the Netherlands., van Breeschoten J; Department of Medical Oncology, Amsterdam University Medical Center, Vrije Universiteit Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Kessels R; Dutch Oncology Research Platform, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Valkenburg-van Iersel LB; Division of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Verheul HM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Buffart TE; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Mekenkamp LJ; Department of Medical Oncology, Medisch Spectrum Twente, Enschede, the Netherlands., Lemmens VE; Board of Directors, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.; Department of Public Health, Erasmus University Medical Centre, Rotterdam, the Netherlands., Koopman M; Department of Medical Oncology, Division Cancer Center and Imaging, University Medical Center Utrecht, Utrecht, the Netherlands., Bol GM; Department of Medical Oncology, Division Cancer Center and Imaging, University Medical Center Utrecht, Utrecht, the Netherlands.

مؤلفون مشاركون: EXCITE (From Clinical Trial to Bedside: Triplet Chemotherapy in Metastatic Colorectal Cancer) Study Group

المصدر: JAMA network open [JAMA Netw Open] 2021 Sep 01; Vol. 4 (9), pp. e2124766. Date of Electronic Publication: 2021 Sep 01.

نوع المنشور: Evaluation Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Bevacizumab/*administration & dosage , Colorectal Neoplasms/*drug therapy , Drug Prescriptions/*statistics & numerical data , Medical Oncology/*statistics & numerical data , Patient Acceptance of Health Care/*statistics & numerical data, Aged ; Cross-Sectional Studies ; Female ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Male ; Middle Aged ; Netherlands ; Oxaliplatin/administration & dosage ; Research Design

المؤلفون: Walma MS; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Brada LJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Patuleia SIS; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Blomjous JG; Dept. of Radiology, OLVG, Amsterdam, the Netherlands., Bollen TL; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Bosscha K; Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Bruijnen RC; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Busch OR; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Daams F; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Dam R; Dept. of Surgery, Maastricht UMC+, Maastricht, the Netherlands., Festen S; Dept. of Surgery, OLVG, Amsterdam, the Netherlands., Jan de Groot D; Dept. of Medical Oncology, UMC Groningen, Groningen, the Netherlands., Willem de Groot J; Dept. of Medical Oncology, Isala Clinics, Zwolle, the Netherlands., Mohammad NH; Dept. of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Hermans JJ; Dept. of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands., de Hingh IH; Dept. of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Kerver ED; Dept. of Medical Oncology, OLVG, Amsterdam, the Netherlands., van Leeuwen MS; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., van der Leij C; Dept. of Radiology, Maastricht UMC+, Maastricht, the Netherlands., Liem MS; Dept. of Surgery, Medical Spectrum Twente, Enschede, the Netherlands., van Lienden KP; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Los M; Dept. of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., de Meijer VE; Dept. of Surgery, UMC Groningen, Groningen, the Netherlands., Meijerink MR; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Mekenkamp LJ; Dept. of Medical Oncology, Medical Spectrum Twente, Enschede, the Netherlands., Nederend J; Dept. of Radiology, Catharina Hospital, Eindhoven, the Netherlands., Nio CY; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Patijn GA; Dept. of Surgery, Isala Clinics, Zwolle, the Netherlands., Polée MB; Dept. of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Pruijt JF; Dept. of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Renken NS; Dept. of Radiology, Reinier de Graaf Hospital, Delft, the Netherlands., Rombouts SJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Schouten TJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Stommel MWJ; Dept. of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Verweij ME; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., de Vos-Geelen J; Dept. of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands., de Vries JJJ; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Vulink A; Dept. of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands., Wessels FJ; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Wilmink JW; Dept. of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam; the Netherlands., van Santvoort HC; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Besselink MG; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: m.g.besselink@amc.nl., Molenaar IQ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Mar; Vol. 47 (3 Pt B), pp. 699-707. Date of Electronic Publication: 2020 Nov 26.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatectomy*, Adenocarcinoma/*therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*therapy, Adenocarcinoma/pathology ; Aged ; Albumins/administration & dosage ; Antimetabolites, Antineoplastic/therapeutic use ; Cohort Studies ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Neoadjuvant Therapy ; Oxaliplatin/therapeutic use ; Paclitaxel/administration & dosage ; Pancreatic Neoplasms/pathology ; Prospective Studies ; Response Evaluation Criteria in Solid Tumors ; Survival Rate ; Gemcitabine

المؤلفون: Brada LJH; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: l.j.brada@amsterdamumc.nl., Walma MS; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Dam RM; Dept. of Surgery, Maastricht UMC, Maastricht, the Netherlands., de Vos-Geelen J; Dept. of Internal Medicine, Div. of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands., de Hingh IH; Dept. of Surgery, Catharina Hospital, Eindhoven, the Netherlands; Dept. of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Liem MS; Dept. of Surgery, Medical Spectrum Twente, Enschede, the Netherlands., Mekenkamp LJ; Dept. of Medical Oncology, Medical Spectrum Twente, Enschede, the Netherlands., de Meijer VE; Dept. of Surgery, UMC Groningen, Groningen, the Netherlands., de Groot DJA; Dept. of Medical Oncology, UMC Groningen, Groningen, the Netherlands., Patijn GA; Dept. of Surgery, Isala, Zwolle, the Netherlands., de Groot JWB; Isala Oncology Center, Isala, Zwolle, the Netherlands., Festen S; Dept. of Surgery, OLVG, Amsterdam, the Netherlands., Kerver ED; Dept. of Medical Oncology, OLVG, Amsterdam, the Netherlands., Stommel MWJ; Dept. of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Meijerink MR; Dept. of Radiology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands., Bosscha K; Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Pruijt JF; Dept. of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Polée MB; Dept. of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ropela JA; Dept. of Medical Oncology, St Jansdal Hospital, Harderwijk, the Netherlands., Cirkel GA; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Los M; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Wilmink JW; Dept. of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Haj Mohammad N; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., van Santvoort HC; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Besselink MG; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Molenaar IQ; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. Electronic address: i.q.molenaar@umcutrecht.nl.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2021 Jan; Vol. 21 (1), pp. 163-169. Date of Electronic Publication: 2020 Dec 03.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 100966936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1424-3911 (Electronic) Linking ISSN: 14243903 NLM ISO Abbreviation: Pancreatology Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms/*mortality , Pancreatic Neoplasms/*therapy, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Chemoradiotherapy ; Drug Therapy ; Female ; Humans ; Induction Chemotherapy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Registries ; Survival Analysis ; Young Adult

المؤلفون: de Klein GW; Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands., van Baarlen J; Laboratorium Pathologie Oost-Nederland (LabPON), Hengelo, The Netherlands., Mekenkamp LJ; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands., Liem MSL; Department of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands., Klaase JM; Department of Surgery, Universitair Medisch Centrum Groningen, Groningen, The Netherlands.

المصدر: Case reports in gastroenterology [Case Rep Gastroenterol] 2018 Apr 27; Vol. 12 (1), pp. 194-201. Date of Electronic Publication: 2018 Apr 27 (Print Publication: 2018).

نوع المنشور: Case Reports

بيانات الدورية: Publisher: Karger Country of Publication: Switzerland NLM ID: 101474819 Publication Model: eCollection Cited Medium: Print ISSN: 1662-0631 (Print) Linking ISSN: 16620631 NLM ISO Abbreviation: Case Rep Gastroenterol Subsets: PubMed not MEDLINE

المؤلفون: de Ridder JAM; Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: jannemarie.deridder@radboudumc.nl., van der Stok EP; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mekenkamp LJ; Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., Wiering B; Department of Surgery, Slingeland Hospital, Doetinchem, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, The Netherlands., Punt CJA; Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands., Verhoef C; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., de Wilt JH; Department of Surgical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 May; Vol. 59, pp. 13-21. Date of Electronic Publication: 2016 Mar 16.

نوع المنشور: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms* , Rectal Neoplasms*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Liver Neoplasms/*surgery, Adult ; Aged ; Bevacizumab/administration & dosage ; Capecitabine/administration & dosage ; Case-Control Studies ; Cetuximab/administration & dosage ; Female ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/secondary ; Lymphatic Metastasis ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Retrospective Studies ; Survival Analysis

المؤلفون: Hugen N; Department of Surgery, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Simmer F; Department of Pathology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Mekenkamp LJ; Department of Internal Medicine, Medical Spectrum Twente Enschede, 7500 KA Enschede, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands., van den Broek E; Department of Pathology, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands., de Wilt JH; Department of Surgery, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center University of Amsterdam, 1100 DD Amsterdam, The Netherlands., Ylstra B; Department of Pathology, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands., Meijer GA; Department of Pathology, VU University Medical Centre, 1007 MB Amsterdam, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.

المصدر: Oncotarget [Oncotarget] 2015 Sep 22; Vol. 6 (28), pp. 25715-25.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: DNA Copy Number Variations* , Gene Dosage*, Adenocarcinoma, Mucinous/*genetics , Biomarkers, Tumor/*genetics , Colorectal Neoplasms/*genetics, Adenocarcinoma, Mucinous/mortality ; Adenocarcinoma, Mucinous/pathology ; Adenocarcinoma, Mucinous/therapy ; Chromosomal Instability ; Chromosomes, Human, Pair 18 ; Chromosomes, Human, Pair 20 ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Colorectal Neoplasms/therapy ; Databases, Genetic ; Genetic Predisposition to Disease ; Humans ; Kaplan-Meier Estimate ; Phenotype ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Risk Factors ; Time Factors

المؤلفون: Simmer F; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Venderbosch S; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Dijkstra JR; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Vink-Börger EM; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Faber C; Institute of Pathology, Ludwig-Maximilians-University of München, München, Germany., Mekenkamp LJ; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., De Haan AF; Department for Health Evidence, Section Biostatistics, Radboud University Medical Center, Nijmegen, The Netherlands., Punt CJ; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.

المصدر: Oncotarget [Oncotarget] 2015 Sep 08; Vol. 6 (26), pp. 22996-3007.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*genetics , MicroRNAs/*biosynthesis, Biomarkers, Tumor ; Camptothecin/administration & dosage ; Camptothecin/analogs & derivatives ; Capecitabine/administration & dosage ; Clinical Trials, Phase III as Topic ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Disease-Free Survival ; Drug Resistance, Neoplasm ; Female ; Humans ; Immunohistochemistry ; Irinotecan ; Male ; MicroRNAs/genetics ; Multicenter Studies as Topic ; Neoplasm Metastasis ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Randomized Controlled Trials as Topic

المؤلفون: Mekenkamp LJ; Departments of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands., Beishuizen A, Slomp J, Legdeur MC, Klaase JM, Trof RJ

المصدر: The Netherlands journal of medicine [Neth J Med] 2015 May; Vol. 73 (4), pp. 182-6.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Internet ISSN: 1872-9061 (Electronic) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: MEDLINE

مواضيع طبية MeSH: Pancreaticoduodenectomy*, Coagulants/*therapeutic use , Glucocorticoids/*therapeutic use , Hemophilia A/*therapy , Immunosuppressive Agents/*therapeutic use , Intestinal Fistula/*surgery , Pancreatic Neoplasms/*surgery , Postoperative Complications/*therapy , Postoperative Hemorrhage/*therapy, Aged ; Blood Transfusion ; Cyclophosphamide/therapeutic use ; Factor VIII/therapeutic use ; Factor VIIa/therapeutic use ; Hemophilia A/complications ; Humans ; Male ; Postoperative Hemorrhage/etiology ; Recombinant Proteins/therapeutic use

SCR Disease Name: Factor 8 deficiency, acquired